The pharmacokinetics of perioperative systemic antibiotics and the microbiological effectiveness of oral nonabsorbable antibiotics started immediately prior to surgery were studied in 18 adult patients undergoing liver transplantation. All patients received cefotaxime, 2 g intravenously, at 6-h intervals during surgery and then at 8-h intervals thereafter for 48 h; eight patients also received ampicillin at the same dose and schedule. This regimen produced levels of antibiotics in blood that appeared appropriate for prophylaxis. The first dose peak (68 ± 18 ,ig/ml) and trough (6.9 + 4.7 ,g/ml) levels of cefotaxime in serum and the first dose peak (73 ± 22 ,ug/ml) and trough (4.1 + 2.3 ,ug/ml) levels of ampicillin in serum, which were assayed by high-performance liquid chromatography, were similar to levels reported in normal volunteers, despite mean intraoperative blood loss of 3.3 liters and fluid replacement of 21 liters. On postoperative days 1 and 2, the levels of cefotaxime and ampicillin were maintained at or above 0.9 and 1.3 pg/ml, respectively, with little accumulation. By random assignment, 8 patients received systemic antibiotics alone and 10 patients received systemic antibiotics plus a 3-week regimen of oral nonabsorbable antibiotics (gentamicin, polymyxin E, and nystatin) beginning when a donor liver was procured. Pre-and postoperative cultures of rectum, throat, and gastric aspirate samples showed persistence of aerobic gram-negative bacilli for the first 2 postoperative weeks in about half of the patients in each group. Failure of the regimen of oral nonabsorbable antibiotics to supplement cefotaxime in eradicating aerobic gram-negative bacilli from stools probably results from impaired peristalsis during and after surgery and warrants earlier initiation of the regimen.
± 22 ,ug/ml) and trough (4.1 + 2.3 ,ug/ml) levels of ampicillin in serum, which were assayed by high-performance liquid chromatography, were similar to levels reported in normal volunteers, despite mean intraoperative blood loss of 3.3 liters and fluid replacement of 21 liters. On postoperative days 1 and 2, the levels of cefotaxime and ampicillin were maintained at or above 0.9 and 1.3 pg/ml, respectively, with little accumulation. By random assignment, 8 patients received systemic antibiotics alone and 10 patients received systemic antibiotics plus a 3-week regimen of oral nonabsorbable antibiotics (gentamicin, polymyxin E, and nystatin) beginning when a donor liver was procured. Pre-and postoperative cultures of rectum, throat, and gastric aspirate samples showed persistence of aerobic gram-negative bacilli for the first 2 postoperative weeks in about half of the patients in each group. Failure of the regimen of oral nonabsorbable antibiotics to supplement cefotaxime in eradicating aerobic gram-negative bacilli from stools probably results from impaired peristalsis during and after surgery and warrants earlier initiation of the regimen.
Bacterial and fungal infections frequently complicate orthotopic liver transplantation (OLT), despite routine perioperative prophylaxis with broad-spectrum antibiotics and sometimes antifungal agents. Most liver transplant patients experience at least one serious bacterial infection (11, 16) , and the incidence of fungal infection has ranged from 16 to 42% (4, 6, 17, 38) . The characteristics of posttransplant bacterial and fungal infections are that most occur during the first few weeks after transplantation; the predominant pathogens in each category are aerobic gram-negative bacilli (AGNB) and Candida albicans; and the most common sites of infection are the abdomen, lower respiratory tract, and bloodstream (4, 6, 11, 16, 17, 38) . These features suggest that posttransplant infections usually result from perioperative inoculation or translocation of potentially pathogenic bowel flora into the abdomen and bloodstream or from aspiration of oropharyngeal AGNB.
In an effort to reduce the incidence of posttransplant infection beyond that achieved with systemic antibiotic prophylaxis, several centers have supplemented systemic antibiotics with regimens of topical oropharyngeal and oral nonabsorbable antimicrobial agents to selectively eliminate AGNB and yeasts from the bowel and oropharynx (30, 37, 40) . These selective bowel decontamination (SBD) regimens appear promising on the basis of the likely pathogenesis of posttransplant infections and the efficacy of SBD in diverse groups of patients, including those with cirrhosis (29, 32) (19, 36) .
The regimens for administration of systemic and nonabsorbable antibiotics for SBD to other groups of patients may not be appropriate for liver transplant recipients. Administration of systemic antibiotics during OLT may require modification because of extensive intraoperative blood loss, often exceeding two blood volumes (11, 30) , which may hasten antibiotic elimination. Also, the timing of administration of oral nonabsorbable antibiotics, which often take at least 1 week to achieve SBD (19) , is problematic because of uncertainty about when a donor liver will be available. Interest in these issues, which may affect the efficacy of antibiotic prophylaxis, prompted us to conduct a pilot study in which we assessed the pharmacokinetics of systemic agents and the microbiological effectiveness of an SBD regimen started immediately prior to surgery.
MATERIALS AND METHODS
Patients. Patients who underwent OLT at the University of Chicago Hospital during August 1988 to September 1990 were asked to participate in this study, which had institutional review board approval. Patients were eligible if they were not allergic to any of the study antibiotics and had not received systemic antibiotics for at least 3 days prior to transplantation.
Regimens. Subjects were randomized to receive one of four prophylaxis regimens: (i) intravenous (i.v.) cefotaxime; (ii) i.v. cefotaxime and i.v. ampicillin; (iii) i.v. cefotaxime and oral nonabsorbable antibiotics; or (iv) i.v. cefotaxime, i.v. ampicillin, and oral nonabsorbable antibiotics. Twogram doses of cefotaxime or ampicillin were infused over 5 min pre-and intraoperatively and over 30 min postopera-tively. The initial dose of each systemic antibiotic was given 30 to 60 min before surgery, and subsequent doses were given every 6 h intraoperatively and then every 8 h postoperatively for 48 h. The regimen of oral nonabsorbable antibiotics for SBD consisted of a suspension of gentamicin, 80 mg/10 ml; polymyxin E, 100 mg/10 ml; and nystatin, 2 x 106 U/10 ml, plus mucosal paste (Orabase; Colgate-Hoyt, Canton, Mass.) containing the same antibiotics at 2% concentrations. The suspension and paste were administered four times daily as described by Wiesner (40) , but the oral suspension was not started until a donor liver was procured.
Cultures. Swab cultures of the throat and rectum were taken immediately before transplantation surgery and on postoperative days 1, 3, 7, and 14. Gastric secretions were aspirated for culture on the same days if the patient still had a nasogastric tube. Also, during both the first and last hours of surgery, specimens were obtained from the proximal jejunum and mid-transverse colon by injecting 10 ml of normal saline into a 15-cm segment of bowel isolated between noncrushing clamps, mixing for 15 s, and then aspirating 1 to 2 ml for culture (1) . Specimens were inoculated by using the four-quadrant streaking method (9) for semiquantitative culture onto Trypticase soy agar with 5% sheep blood, Columbia CNA agar, MacConkey agar, and Sabouraud dextrose agar (BBL, Cockeysville, Md.). Plates were incubated at 35°C for 24 to 48 h, and AGNB were identified by using a commercially available kit (API 20E; Analylab Products, Inc., Plainview, N.Y.). The antibiotic susceptibilities of the bacteria were determined by broth microdilution by using an automated system (AutoMicrobic System; Vitek Systems, Hazelwood, Mo.).
Antibiotic kinetics. Intraoperatively, 5-ml samples of blood were obtained for determination of cefotaxime, desacetylcefotaxime, and ampicillin concentrations in serum prior to each dose and at 5, 15, 30, 60, 120, 180, 240, 300, and 360 min following antibiotic infusion. The desacetylcefotaxime concentration was measured because this metabolite has antibacterial activity. Additional samples were drawn 24 and 48 h after surgery to measure trough (within 30 min before drug administration) and peak (30 min following drug administration) concentrations. Immediately after sample collection, serum was separated and stored at -70°C until assayed by high-performance liquid chromatography. The concentrations of cefotaxime and its desacetyl metabolite in serum were determined by previously described methods (7, 18) , except the ion pair reagent was tetrabutylammonium hydroxide (pH 6.2) and the volumes of the reagents added to the 200-,ul plasma sample for extraction were 25 ,ul of 0.45 N H3PO4 and 1,000 RI of methanol. Assay sensitivity was 0.1 to 0.2 ,ug/ml; the coefficients of variation within days and between days were 5 and 8%, respectively, for low concentrations; and the coefficients of variation within days and between days were 2 and 5%, respectively, for high concentrations. The concentrations of ampicillin in serum were assayed by using the acetonitrile protein precipitation and the reversed-phase high-performance liquid chromatographic methods described by Noonon et al. (24) . Assay sensitivity was 0.1 ,ug/ml; within-and between-day coefficients of variation for high concentrations were 5 and 8%, respectively, and within-and between-day coefficients of variation for low concentrations were both 10%.
By using the computer program RSTRIP (10), the elimination rate constant (kel) for each antibiotic was calculated by nonlinear regression analysis of the terminal log-linear portion (last three to six datum points) of the serum concentration-time curve following the first dose. The elimination (25) . The total body clearance of antibiotics was determined by dividing the antibiotic dose by the area under the concentration-time curve (AUC) from time zero to infinity. The volume of distribution at steady state was determined by dividing the product of the dose and the area under the first moment of the concentration-time curve from time zero to infinity by the AUC2 from time zero to infinity. Both AUC and the area under the first moment of the concentration-time curve were approximated by the linear trapezoidal rule to the last measured drug concentration in serum. The elimination rate constant was used to calculate residual areas for AUC and the area under the first moment of the concentration-time curve.
RESULTS
Patients and regimens. The characteristics of the 18 study participants are summarized in Table 1 . Adequate specimens for antibiotic level determinations were obtained from 15 patients, and appropriate specimens for culture were obtained from 17 patients. Ten patients from whom samples for culture were obtained received oral nonabsorbable antibiotics. The median interval between the first dose and the start of transplant surgery in nine of these patients was 3 h. In the other patient, surgery was canceled unexpectedly, and oral nonabsorbable antibiotics were continued for 18 days until another donor liver became available.
Cultures. During the 2 weeks following transplantation surgery, about half of the patients who received systemic plus oral nonabsorbable antibiotics continued to have AGNB in their stools. The overall rate of positive postoperative rectal swab cultures in these patients was 48% (14 of 29 specimens), whereas the rate was 58% (11 of 19 specimens) for patients who received systemic antibiotics alone. At each of the intervals after transplantation when rectal swab cultures were obtained, the percentage of specimens positive for AGNB was not significantly different in the two groups of patients ( Table 2 ). Growth of AGNB on rectal swab primary plates extended to the third or fourth quadrant (moderate or heavy growth, respectively) in 9 (64%) of 14 positive specimens from patients receiving the SBD regimen and in 10 (91%) of 11 positive specimens from patients who received systemic antibiotics alone. All isolates were members of the family Enterobacteriaceae, and the predominant species was Escherichia coli (24 of 32 isolates).
Rates of isolation of AGNB from intraoperative aspirates ofjejunum and transverse colon were similar in patients who received the SBD regimen and those who did not ( Table 2) . None of 39 gastric aspirate specimens and only 1 of 68 pharyngeal swab specimens grew AGNB.
Two patients, both of whom received only systemic antibiotic prophylaxis, either acquired a new strain or experienced a reemergence of a previous species of AGNB during the first 2 weeks after surgery. In one patient, cefotaximesusceptible E. coli was present in a preoperative rectal swab specimen and intraoperative colon aspirates, but no AGNB were detected in rectal swabs on postoperative days 1 and 3. On day 7, cefotaxime-susceptible E. coli again was recovered from a rectal swab. In the other patient, cefotaximesusceptible Enterobacter cloacae was recovered from intraoperative colon aspirates, but the first two postoperative rectal swabs, which were taken on days 1 and 7, were negative for AGNB. Cultures of a throat swab obtained on day 7 and a rectal swab specimen obtained on day 14 grew cefotaxime-resistant E. cloacae.
The possible emergence of cefotaxime-resistant strains of AGNB could be assessed in 14 patients who had cefotaximesusceptible AGNB in their stools at the time that systemic antibiotic prophylaxis was started (positive preoperative and/or intraoperative cultures) and from whom at least two rectal swab cultures were obtained after surgery. The isolates of AGNB in stool specimens at the start of perioperative prophylaxis were E. coli (13 patients), E. cloacae (7 patients), Kiebsiella pneumoniae (3 patients), Proteus mirabilis (1 patient), and Citrobacterfreundii (1 patient). The only patient in whom there was the possible emergence of a cefotaxime-resistant strain was the patient with E. cloacae described above. Thus, among the seven patients with E. cloacae colonization at the time of OLT, in one of three patients given cefotaxime alone and none of four patients given cefotaxime plus oral nonabsorbable antibiotics was there a possible emergence of cefotaxime-resistant E. cloacae.
Antibiotic kinetics. The concentrations of the systemic antibiotics in serum following the first and second intraoperative doses are plotted in Fig. 1 . Antibiotic concentrations at selected times are displayed in Table 3 . The lowest intraoperative concentration of cefotaxime (first dose trough) in serum was 0.9 ,ug/ml in one patient; in all other patients the trough concentration was 23.9 ,ug/ml. The lowest intraoperative concentration of ampicillin was 1.0 ,ug/ml. The calculated first-dose pharmacokinetic parameters of cefotaxime, desacetylcefotaxime, and ampicillin are summarized in Table 4 . Trough levels of cefotaxime on postoperative days 1 and 2 ranged from 0.9 to 10.4 ,ug/ml, and levels of ampicillin at the same times ranged from 1.3 to 20.0 ,ug/ml.
DISCUSSION
The regimen of oral nonabsorbable antibiotics used for SBD in the present study did not appear to substantially augment the effect of systemic cefotaxime in eradicating (37) generally began taking oral nonabsorbable antibiotics at least 1 week prior to transplantation. In the latter series, cultures at the time of surgery were positive for AGNB only from patients who had been taking the SBD regimen for less than 1 week. At another center where the SBD regimen was started 6 to 8 h before surgery, presumably at the time a donor liver was located, 36% of patients still had SBD-susceptible organisms in their stools after 5 days (30) . Other patient populations given the same oral regimens as those given to liver transplant recipients have also shown a gradual decline over 1 to 2 weeks in the proportion of individuals with AGNB in their stools (19, 33) .
The importance of eradicating AGNB and yeasts from the gut by the time of transplantation surgery has not been clearly shown. Nonetheless, available information from uncontrolled studies (37, 40) and one study that used concurrent, unsuccessfully treated controls (30) indicates that successful SBD probably is beneficial. Because of the sometimes lengthy interval until SBD is achieved, especially in patients whose gut peristalsis is impaired by surgery, it appears advisable to begin administering oral nonabsorbable antibiotics for SBD at least several days before a donor liver is sought.
A further benefit that may result from administering oral nonabsorbable antibiotics in addition to cefotaxime is that the oral regimen is effective in eliminating most cefotaximeresistant AGNB (34) and presumably can prevent the emergence of populations of AGNB that can markedly increase their P-lactamase production. This is an important consideration, because previous administration of broad-spectrum cephalosporins has been associated with the emergence of beta-lactam resistance by some AGNB (31) and especially with multi-drug-resistant Enterobacter bacteremia (5, 14) . In the present study, eight patients initially had intestinal colonization by organisms (E. cloacae or C. freundii) that characteristically can markedly increase their ,B-lactamase production (31) . In none of the four patients given cefotaxime plus the SBD regimen did a cefotaxime-resistant strain of AGNB emerge. Cefotaxime-resistant E. cloacae was detected postoperatively in the throat and then in the stool of one of the four patients (three with E. cloacae and one with C. freundii) who received cefotaxime without the SBD regimen. The isolates were not typed to ascertain whether this represented emergence of resistance or the acquisition of a new strain.
Cefotaxime, usually in combination with tobramycin or ampicillin, commonly is administered perioperatively for prophylaxis of infection in liver transplant patients. Conventional dosing of cefotaxime and ampicillin has been 1 g every 6 h for 1 to 5 days (16, 30, 37, 40) . While this dose generally yields adequate trough levels of both antibiotics in normal volunteers (2, 8, 21, 23) and has even been shown in liver transplant recipients to result in the accumulation of cefotaxime and desacetylcefotaxime in the postoperative period (3), we chose a larger dose (2 g) for this study because of concern that extensive intraoperative blood loss would lower antibiotic levels in serum during that critical period.
Concentrations of cefotaxime and ampicillin in serum intraoperatively were similar to the levels in normal volunteers. These results are surprising, since lowered antibiotic levels have been found in other patients who underwent lengthy operations with extensive blood loss (20) . Substantial distribution of cefotaxime and ampicillin into extravascular fluids and tissues that act as reservoirs from which the antibiotics can reenter the circulation probably is an important factor contributing to the "normal" levels in serum in the liver transplant patients we studied (35) . Also, the impaired hepatic and renal functions of our patients probably increased the elimination half-lives of cefotaxime and ampicillin intraoperatively (15, 22, 41) , partially compensating for antibiotic loss caused by bleeding.
The levels of perioperative antibiotics in serum needed to minimize the rates of postoperative infection have not been ascertained. The issue is complex; and a variety of other factors may be important, e.g., antibiotic penetration into cells, tissues, and fluids; dose-dependent bactericidal activity; and postantibiotic effect (28) . Nonetheless, the available information from prophylaxis studies with other cephalosporin antibiotics indicates that absent or low levels in tissues or serum are associated with a higher risk of infection (12, 26, 27) . Our finding that aggressive dosing of cefotaxime and ampicillin was needed to maintain trough levels in serum several times above the MICs for susceptible organisms suggests that such dosing may be warranted, at least intraoperatively, in liver transplant patients.
